J2711 – Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2711
- Long description
- Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- Short description
- Inj neostigmin/glycopyrrolat
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2026
- Last change
- January 1, 2026 – No change
Frequently asked questions
What is HCPCS code J2711?
J2711 is a HCPCS Level II code for injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg.
Does Medicare cover J2711?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2670 – Injection, tolazoline hcl, up to 25 mg
- J2675 – Injection, progesterone, per 50 mg
- J2679 – Injection, fluphenazine hcl, 1.25 mg
- J2680 – Injection, fluphenazine decanoate, up to 25 mg
- J2690 – Injection, procainamide hcl, up to 1 gm
- J2700 – Injection, oxacillin sodium, up to 250 mg
- J2704 – Injection, propofol, 10 mg
- J2710 – Injection, neostigmine methylsulfate, up to 0.5 mg
- J2720 – Injection, protamine sulfate, per 10 mg
- J2724 – Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 – Injection, protirelin, per 250 mcg
- J2730 – Injection, pralidoxime chloride, up to 1 gm
- J2760 – Injection, phentolamine mesylate, up to 5 mg
- J2765 – Injection, metoclopramide hcl, up to 10 mg
- J2770 – Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 – Injection, faricimab-svoa, 0.1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.